newsfilter
← Latest News
CNBC·

Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO

Summary

  • Isomorphic Labs raised a $5 billion Series C round on Tuesday.
  • The startup was founded by former Google DeepMind chief Demis Hassabis.
  • The funding round was co-led by Greenoaks & Sequoia Capital, with participation from Andreessen Horowitz & Alphabet.
  • The capital will support the design & development of new medicines using artificial intelligence.
  • Hassabis has served as CEO of Isomorphic Labs since the company spun out of DeepMind in 2021.
  • The company is building a proprietary drug design engine & therapeutic candidate pipeline.
  • Drug discovery startups raised a record $23.2 billion in 2026 according to Dealroom.
  • Isomorphic previously raised $2.1 billion in a Series B round in May.
  • Competitors OpenAI & Anthropic have also invested in AI-driven drug discovery tools.

Isomorphic Labs is looking to develop new medicines using AI.

Keywords
Breaking News: Technology,Technology,Pharmaceuticals,Demis Hassabis,Alphabet Class A,Novo Nordisk A/S,business news